Matches in SemOpenAlex for { <https://semopenalex.org/work/W2117879974> ?p ?o ?g. }
Showing items 1 to 78 of
78
with 100 items per page.
- W2117879974 endingPage "e2" @default.
- W2117879974 startingPage "e2" @default.
- W2117879974 abstract "<h3>Aims</h3> The aim of this Cochrane review is to evaluate the efficacy and safety of atypical antipsychotics compared with placebo in treating tics in patients with Tourette syndrome (TS). <h3>Methods</h3> We cross referenced atypical antipsychotics-risperidone, olanzapine, clozapine, amisulpiride, quetiapine, loxapine, ziprasidone, clotiapine, aripiprazole, remoxipride, sertindole, zotepine, sulpiride and their proprietary names with “Tourette Syndrome” and its derivations and searched the Cochrane Movement Disorder Group Trials Register, Cochrane Central Register of Controlled Trials (CENTRAL) (The Cochrane Library 2010, issue 3), MEDLINE (1950–2010), EMBASE (1980–2010), PsycINFO(1987–2010), and CINAHL (2010). Grey literature, reference lists, hand searching, clinical trials websites and pharmaceutical company sites were also searched. All relevant randomised, controlled, double blind studies were considered for inclusion in this review. <h3>Results</h3> The search identified three randomised controlled trials, two comparing risperidone and one comparing ziprasidone with placebo. Risperidone was superior to placebo in one trial although the 95% CIs were very large. Two trials showed no statistical difference between risperidone and ziprasidone against placebo. Methodological quality was rated as “unclear”. Clinical heterogeneity made meta-analysis inappropriate. <h3>Conclusions</h3> It is difficult to draw clear conclusions from the identified trials in the review as evidence is limited. Placebo controlled trials with longer duration and larger groups are needed to investigate the safety and efficacy of atypical antipsychotics as a pharmaceutical class in TS populations." @default.
- W2117879974 created "2016-06-24" @default.
- W2117879974 creator A5015495720 @default.
- W2117879974 creator A5064901701 @default.
- W2117879974 creator A5068156890 @default.
- W2117879974 date "2011-07-07" @default.
- W2117879974 modified "2023-09-27" @default.
- W2117879974 title "PA.14 Atypical antipsychotics for Tourette syndrome" @default.
- W2117879974 doi "https://doi.org/10.1136/jnnp-2011-300504.41" @default.
- W2117879974 hasPublicationYear "2011" @default.
- W2117879974 type Work @default.
- W2117879974 sameAs 2117879974 @default.
- W2117879974 citedByCount "0" @default.
- W2117879974 crossrefType "journal-article" @default.
- W2117879974 hasAuthorship W2117879974A5015495720 @default.
- W2117879974 hasAuthorship W2117879974A5064901701 @default.
- W2117879974 hasAuthorship W2117879974A5068156890 @default.
- W2117879974 hasConcept C118552586 @default.
- W2117879974 hasConcept C126322002 @default.
- W2117879974 hasConcept C142724271 @default.
- W2117879974 hasConcept C15744967 @default.
- W2117879974 hasConcept C168563851 @default.
- W2117879974 hasConcept C187212893 @default.
- W2117879974 hasConcept C204787440 @default.
- W2117879974 hasConcept C27081682 @default.
- W2117879974 hasConcept C2776412080 @default.
- W2117879974 hasConcept C2776478404 @default.
- W2117879974 hasConcept C2776619155 @default.
- W2117879974 hasConcept C2776921671 @default.
- W2117879974 hasConcept C2777026814 @default.
- W2117879974 hasConcept C2777270317 @default.
- W2117879974 hasConcept C2780057945 @default.
- W2117879974 hasConcept C2780211496 @default.
- W2117879974 hasConcept C2780494398 @default.
- W2117879974 hasConcept C2780634440 @default.
- W2117879974 hasConcept C2780777758 @default.
- W2117879974 hasConcept C71924100 @default.
- W2117879974 hasConceptScore W2117879974C118552586 @default.
- W2117879974 hasConceptScore W2117879974C126322002 @default.
- W2117879974 hasConceptScore W2117879974C142724271 @default.
- W2117879974 hasConceptScore W2117879974C15744967 @default.
- W2117879974 hasConceptScore W2117879974C168563851 @default.
- W2117879974 hasConceptScore W2117879974C187212893 @default.
- W2117879974 hasConceptScore W2117879974C204787440 @default.
- W2117879974 hasConceptScore W2117879974C27081682 @default.
- W2117879974 hasConceptScore W2117879974C2776412080 @default.
- W2117879974 hasConceptScore W2117879974C2776478404 @default.
- W2117879974 hasConceptScore W2117879974C2776619155 @default.
- W2117879974 hasConceptScore W2117879974C2776921671 @default.
- W2117879974 hasConceptScore W2117879974C2777026814 @default.
- W2117879974 hasConceptScore W2117879974C2777270317 @default.
- W2117879974 hasConceptScore W2117879974C2780057945 @default.
- W2117879974 hasConceptScore W2117879974C2780211496 @default.
- W2117879974 hasConceptScore W2117879974C2780494398 @default.
- W2117879974 hasConceptScore W2117879974C2780634440 @default.
- W2117879974 hasConceptScore W2117879974C2780777758 @default.
- W2117879974 hasConceptScore W2117879974C71924100 @default.
- W2117879974 hasIssue "8" @default.
- W2117879974 hasLocation W21178799741 @default.
- W2117879974 hasOpenAccess W2117879974 @default.
- W2117879974 hasPrimaryLocation W21178799741 @default.
- W2117879974 hasRelatedWork W125839487 @default.
- W2117879974 hasRelatedWork W1509131650 @default.
- W2117879974 hasRelatedWork W1570131271 @default.
- W2117879974 hasRelatedWork W1979499491 @default.
- W2117879974 hasRelatedWork W2013970121 @default.
- W2117879974 hasRelatedWork W2016284931 @default.
- W2117879974 hasRelatedWork W2036715112 @default.
- W2117879974 hasRelatedWork W2050310642 @default.
- W2117879974 hasRelatedWork W2069335275 @default.
- W2117879974 hasRelatedWork W2117879974 @default.
- W2117879974 hasVolume "82" @default.
- W2117879974 isParatext "false" @default.
- W2117879974 isRetracted "false" @default.
- W2117879974 magId "2117879974" @default.
- W2117879974 workType "article" @default.